Skip to main content

Table 5 Hemodynamics and cardiac physiology parameters

From: The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats

Parameter Group
Control Empagliflozin
Systolic BP [mmHg] 115 ± 17 126 ± 14
Diastolic BP [mmHg] 78 ± 13 91 ± 11
HR [bpm] 454 ± 76 374 ± 68
SV [µl] 98 ± 12 112 ± 23
CO [m/min] 19.7 ± 3.1 22.3 ± 3.8
EF [%] 23.2 ± 2.7 25.8 ± 6.2
SW [mmHg*µl] 6680 ± 2208 7175 ± 2822
dp/dt max [mmHg/sec] 5252 ± 2011 5453 ± 441
dp/dt min [mmHg/sec] − 3324 ± 1547 − 3417 ± 771
  1. BP blood pressure, HR Heart rate, SV stroke volume, CO cardiac output, EF ejection fraction, SW stroke work, dp/dt max and min rate of pressure change at systole and diastole, respectively